Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Janus Global Life Sciences D Shs: (MF: JNGLX)

(MF) As of Aug 29, 2014 06:05 PM ET

 Add to portfolio

$52.98 USD

+0.33 (0.63%)

Zacks MF Rank : 4 - Sell [?]       4  

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Jul 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Jul 31, 2014) 14.09
Objective Health Care - Equity
Peer HL LG

Zacks Premium Research for JNGLX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Sell 4
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 27.69
Net Assets (Mil $) 7/31/2014 1,079.71
%Turnover 7/31/2014 46.00

Allocation

% of Portfolio
Large Growth 44.24
Large Value 0.00
Small Growth 9.01
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 21.62
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 7/31/2014 % of Portfolio
Health 50.06
Services 17.46
Other 8.76
Industrial Cyclical 8.15
Finance 6.53
Retail Trade 3.51
Non-Durable 2.45
Technology 2.34
Consumer Durables 0.74

Portfolio Holdings

Top Equity Holdings
(As of 3/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 4.51 90.86
AETNA INC 2.88 58.03
EXPRESS SCRIPTS HOLDING C 2.84 57.12
JOHNSON & JOHNSON 2.76 55.67
CELGENE CORP 2.69 54.13
BIOGEN IDEC INC 2.62 52.82
ROCHE HOLDING AG GENUSSS 2.31 46.48
VALEANT PHARMACEUTICALS 2.19 44.18
ASTRAZENECA 1.79 35.98

Stock Holding % of Net Assets

As Of 3/31/2014
Total Issues 90
Avg. P/E 27.97
Avg. P/Book 5.56
Avg. EPS Growth 17.09
Avg. Market Value (Mil $) 43,551

Risk

3 Year 5 Year 10 Year
Beta 0.85 0.78 0.77
Alpha 13.25 9.54 6.40
R Squared 0.52 0.56 0.58
Std. Dev. 14.47 13.76 14.89
Sharpe 2.07 1.76 1.00